A venture capital fund located in Montreal focused on creating promising life science companies.
AmorChem l.p., our fourth focused fund, was launched in 2011 to increase the commercial potential of the quality academic research carried out in Quebec. AmorChem is focused on investing in promising life science projects originating from Québec-based universities and research centres. AmorChem’s innovative business model involves financing research-stage projects to enable them to reach pre-clinical proof-of-concept in a semi-virtual mode. AmorChem will generate returns through a two-pronged exit strategy:
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 5, 2018 | Grant | $50M | 1 | Venture Capital Catalyst Initiative (VCCI) | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Venture Capital Catalyst Initiative (VCCI) | Yes | Grant |